{"rows":[{"id":4618,"title":"THU-285 Lownonpsychedelic dosed of psilocybin for the therapy of MASLD","authors":"Martina Colognesi, Daniela Gabbia, Andrea Rinaldi, Luciano Cascione, Ilaria Zanotto, Stefano Comai, Katia Sayaf, Andrea Mattarei, Marco Banzato, Gianfranco Pasut, Franco Folli, Lucia Centofanti, Sergio Traversa, M. Pappagallo, Paolo L. Manfredi, Sara De Martin","journal":"Journal of Hepatology","publication_date":"2024-05-31","publication_year":2024,"doi":"10.1016/s0168-8278(24)01739-2","pubmed_id":null,"openalex_id":"https://openalex.org/W4399560207","source_url":"https://doi.org/10.1016/s0168-8278(24)01739-2","substance_tags":"psilocybin","topic_tags":"Pharmacology","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:43","last_checked":"2026-07-04 07:00:35","bibtex":null,"source_record_id":"DOI:10.1016/s0168-8278(24)01739-2","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/s0168-8278(24)01739-2","source_url":"https://doi.org/10.1016/s0168-8278(24)01739-2","doi":"10.1016/s0168-8278(24)01739-2","pmid":"","publication_date":"2024-05-31","importer_version":"2.1.3","text_redistributed":false}},{"id":4617,"title":"WED-123 Female mice with cirrhosis are more prone to acute and chronic effects of psilocybin exposure without tolerance compared to male mice","authors":"Jessica L. Maltman, Derrick Zhao, Alaina M. Jaster, Yunling Tai, Jing Zeng, Javier Maeso-Gonzalez, Huiping Zhou, Jasmohan S. Bajaj","journal":"Journal of Hepatology","publication_date":"2024-05-31","publication_year":2024,"doi":"10.1016/s0168-8278(24)00826-2","pubmed_id":null,"openalex_id":"https://openalex.org/W4399537175","source_url":"https://doi.org/10.1016/s0168-8278(24)00826-2","substance_tags":"psilocybin","topic_tags":"Pharmacology,Animal Study","study_type":"Animal Study","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:43","last_checked":"2026-07-04 07:00:35","bibtex":null,"source_record_id":"DOI:10.1016/s0168-8278(24)00826-2","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/s0168-8278(24)00826-2","source_url":"https://doi.org/10.1016/s0168-8278(24)00826-2","doi":"10.1016/s0168-8278(24)00826-2","pmid":"","publication_date":"2024-05-31","importer_version":"2.1.3","text_redistributed":false}},{"id":4379,"title":"FRI-407 Adding the serotonergic agonist psilocybin to semaglutide as a novel combination therapy to cure MASLD","authors":"Martina Colognesi, Daniela Gabbia, Anna Signor, Stefano Comai, Andrea Mattarei, Gianfranco Pasut, Lucia Centofanti, Stefano La Rosa, Giovanna Finzi, Franco Folli, M. Pappagallo, Paolo L. Manfredi, Sara De Martin","journal":"Journal of Hepatology","publication_date":"2025-04-30","publication_year":2025,"doi":"10.1016/s0168-8278(25)01632-0","pubmed_id":null,"openalex_id":"https://openalex.org/W4410163501","source_url":"https://doi.org/10.1016/s0168-8278(25)01632-0","substance_tags":"psilocybin","topic_tags":"Pharmacology,Receptor Pharmacology","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:40","last_checked":"2026-07-04 07:00:33","bibtex":null,"source_record_id":"DOI:10.1016/s0168-8278(25)01632-0","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/s0168-8278(25)01632-0","source_url":"https://doi.org/10.1016/s0168-8278(25)01632-0","doi":"10.1016/s0168-8278(25)01632-0","pmid":"","publication_date":"2025-04-30","importer_version":"2.1.3","text_redistributed":false}},{"id":1953,"title":"SAT-219 Hepatic 5-HT2B receptor antagonism mediates the anti-steatotic and antifibrotic effects of psilocybin in preclinical MASH models","authors":"Signor Anna, Colognesi Martina, Finzi Giovanna, Gabbia Daniela, Mattarei Andrea, Comai Stefano, Pasut Gianfranco, Folli Franco, Manfredi Paolo, De Martin Sara","journal":"Journal of Hepatology","publication_date":"2026-05-01","publication_year":2026,"doi":"10.1016/s0168-8278(26)01861-1","pubmed_id":null,"openalex_id":"https://openalex.org/W7162520467","source_url":"https://doi.org/10.1016/s0168-8278(26)01861-1","substance_tags":"psilocybin","topic_tags":"Receptor Pharmacology,Animal Study","study_type":"Animal Study","source_name":"Crossref","publication_status":"published","date_added":"2026-07-01 06:52:05","last_checked":"2026-08-09 08:28:47","bibtex":null,"source_record_id":"DOI:10.1016/s0168-8278(26)01861-1","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.1016/s0168-8278(26)01861-1","source_url":"https://doi.org/10.1016/s0168-8278(26)01861-1","doi":"10.1016/s0168-8278(26)01861-1","pmid":"","publication_date":"2026-05-01","importer_version":"2.1.3","text_redistributed":false}}],"total":4,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"Journal of Hepatology","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}